BR100 Decreased By (-0.16%)
BR30 Decreased By (-0.08%)
KSE100 Decreased By (-0.04%)
KSE30 Decreased By (-0.16%)
AGHA 6.46 Increased By ▲ 0.01 (0.16%)
BECO 4.16 No Change ▼ 0.00 (0%)
BML 58.75 Increased By ▲ 1.44 (2.51%)
BOP 28.25 Increased By ▲ 0.10 (0.36%)
CNERGY 12.45 Increased By ▲ 0.04 (0.32%)
CSIL 5.36 No Change ▼ 0.00 (0%)
FCCL 51.30 Decreased By ▼ -0.36 (-0.7%)
FFL 13.89 Decreased By ▼ -0.01 (-0.07%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.70 Decreased By ▼ -0.02 (-0.35%)
KOSM 5.32 Decreased By ▼ -0.01 (-0.19%)
LOTCHEM 24.28 Increased By ▲ 0.03 (0.12%)
MLCF 89.42 Decreased By ▼ -0.22 (-0.25%)
NBP 156.00 Decreased By ▼ -0.57 (-0.36%)
NCPL 49.95 Increased By ▲ 2.93 (6.23%)
NPL 54.90 Increased By ▲ 2.94 (5.66%)
OGDC 299.37 Decreased By ▼ -0.64 (-0.21%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 33.00 Decreased By ▼ -0.01 (-0.03%)
PIBTL 13.12 Decreased By ▼ -0.07 (-0.53%)
PPL 214.40 Increased By ▲ 0.08 (0.04%)
PRL 97.60 Decreased By ▼ -3.84 (-3.79%)
PTC 52.20 Decreased By ▼ -0.04 (-0.08%)
SSGC 23.08 Decreased By ▼ -0.07 (-0.3%)
TBL 9.00 Decreased By ▼ -0.09 (-0.99%)
TELE 7.00 Increased By ▲ 0.02 (0.29%)
TPL 22.02 Decreased By ▼ -0.02 (-0.09%)
TPLP 11.71 Increased By ▲ 0.02 (0.17%)
TREET 22.82 Increased By ▲ 0.02 (0.09%)
TRG 57.06 Decreased By ▼ -0.07 (-0.12%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices IMF-World Bank meetings Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
World

AstraZeneca to supply COVID-19 antibody cocktail to Singapore

Published Updated
Save
1 min
Comments
By Reuters

SINGAPORE: AstraZeneca said on Friday it will supply Singapore with its COVID-19 antibody cocktail, Evusheld, by the end of the year.

Evusheld can act as another layer of protection, alongside vaccines, for people who are at high risk of COVID-19 infection, according to AstraZeneca's statement.

The company did not specify how many courses of the treatment would be supplied to the Southeast Asian city-state.

The US Food and Drug Administration on Wednesday authorised the use of Evusheld to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.

AstraZeneca

Comments

Comments are closed for this article.

More Stories

Browse all stories